Next Generation Migraine Therapies – Chicago
The Next Generation Migraine Therapies (NGMT) initiative is a comprehensive program designed to provide a multi-faceted approach to migraine education offered at no cost to healthcare providers. Brought to you by the American Headache Society, the program covers diagnosis and treatment of migraine and updates on the latest science.
Book Now
Next Generation Migraine Therapies – Chicago
WHO SHOULD ATTEND
This program is designed for neurologists, family practitioners, internists and other health professionals who would like more information on the proper diagnosis and treatment of chronic migraine patients.
PURPOSE/OBJECTIVE
At the conclusion of this activity, attendees should be better able to:
- Recognize the prevalence and epidemiology of migraine and unmet needs on current treatments
- Discuss insights from basic science that underlie the next generation of migraine therapeutics
- Utilize calcitonin gene-related peptide (CGRP)-targeted therapies in migraine prevention
- Individualize and optimize migraine treatment using current and emerging therapeutic options
ACCREDITATION STATEMENT
The American Headache Society® is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
The American Headache Society® designates this Live Activity for a maximum of 6.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For those who register and participate in the Education On Demand program:
The American Headache Society® designates this Enduring Material for a maximum of 2.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
For those who register and attend a live Q&A session after viewing the enduring material:
The American Headache Society® designates this Live Activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
INSTRUCTIONS FOR CLAIMING CME
- Attend sessions for which credit is sought in full (this includes watching on-demand courses).
- Complete the post-activity evaluation.
- A certificate of completion will be available once the evaluation is submitted.
FINANCIAL DISCLOSURES
The planners and faculty for this activity did not have any relationships to disclose unless listed here. All relevant relationships were mitigated prior to the start of the activity according to ACCME Standards.
DISCLOSURE OF COMMERICAL SUPPORT
AbbVie Inc.
Lilly USA, LLC
Next Generation Migraine Therapies – Chicago
| Next Generation Migraine Therapies
September 17, 2022 | Chicago, IL Hyatt Regency O’Hare Chicago | International A/B/C |
|
| 7:00 am – 7:45 am | Course Registration and Continental Breakfast |
| 7:45 am – 8:00 am | Introduction, Program Overview and Pre-test
Michael Marmura, MD, FAHS |
| 8:00 am – 9:00 am | Overview of Migraine |
| 8:00 am – 8:20 am | Migraine: Making the Diagnosis
Michael Marmura, MD, FAHS |
| 8:20 am – 8:45 am | How Do I Explain Migraine to My Patients?
Michael Marmura, MD, FAHS |
| 8:45 am – 9:00 am | Q&A |
| 9:00 am – 10:15 am | Next Generation Acute Treatment: Addressing Unmet Needs |
| 9:00 am – 9:30 am | Overview of Acute Treatment and Best Practices in Migraine
Deborah Friedman, MD, MPH, FAHS |
| 9:30 am – 10:00 am | Advances in Acute Therapies for Migraine and How to Integrate Them Into Your Practice: New Formulations, Ditans and Gepants
Deborah Friedman, MD, MPH, FAHS |
| 10:00 am – 10:15 am | Q&A |
| 10:15 am – 10:30 am | Break |
| 10:30 am – 12:00 pm | Next Generation Preventive Treatment |
| 10:30 am – 10:45 am | How Do We Approach Preventive Migraine Treatment?
Larry Charleston, IV, MD, MS, FAHS |
| 10:45 am – 11:10 am | Monoclonal Antibodies Targeting CGRP and Gepants
Stephanie J. Nahas, MD, MSEd, FAHS |
| 11:10 am – 11:30 am | Behavioral Treatments for Migraine
Scott Powers, PhD, CCH, FAHS |
| 11:30 am – 11:50 am | Updates in Pediatric Migraine
Rashmi Rao, MD |
| 11:50 am – 12:00 pm | Q&A |
| 12:00 pm – 1:15 pm | Working Lunch: Case Discussions
Moderator: Michael Marmura, MD, FAHS |
| 1:15 pm – 1:30 pm | Break |
| 1:30 pm – 3:45 pm | Procedures, Devices and Non-pharmacological Treatment Workshops
Attendees will be broken into two (2) groups. Each group will be assigned a workshop initially and then switch to the other at the break allowing attendees to attend both workshops. Workshop assignment is noted on the back of the attendee name badge. |
| 1:30 pm – 2:30 pm | Workshop 1: Procedures |
| 1:30 pm – 2:00 pm | OnabotulinumtoxinA: Nerve Blocks and Other Procedures for Migraine
Deborah Friedman, MD, MPH, FAHS |
| 2:00 pm – 2:30 pm | Headache Procedures: Hands-on Training
Larry Charleston, IV, MD, MS, FAHS and Deborah Friedman, MD, MPH, FAHS |
| 1:30 pm – 2:30 pm | Workshop 2: Nonpharmacologic Treatments |
| 1:30 pm – 2:00 pm | Behavioral Enhancements to Migraine Management
Scott Powers, PhD, CCH, FAHS |
| 2:00 pm – 2:30 pm | Neuromodulation for Migraine: Current and Future Devices
Stephanie J. Nahas, MD, MSEd, FAHS |
| 2:30 pm – 2:45 pm | Break (attendees switch rooms-workshops repeat) |
| 2:45 pm – 3:45 pm | Workshop 1: Procedures |
| 2:45 pm – 3:15 pm | OnabotulinumtoxinA: Nerve Blocks and Other Procedures for Migraine
Deborah Friedman, MD, MPH, FAHS |
| 3:15 pm – 3:45 pm | Headache Procedures: Hands-on Training
Larry Charleston, IV, MD, MS, FAHS and Deborah Friedman, MD, MPH, FAHS |
| 2:45 pm – 3:45 pm | Workshop 2: Nonpharmacologic Treatments |
| 2:45 pm – 3:15 pm | Behavioral Enhancements to Migraine Management
Scott Powers, PhD, CCH, FAHS |
| 3:15 pm – 3:45 pm | Neuromodulation for Migraine: Current and Future Devices
Stephanie J. Nahas, MD, MSEd, FAHS |
| 3:45 pm | Closing Remarks and Post-Test
Michael Marmura, MD, FAHS |
Book Now
Next Generation Migraine Therapies – Chicago
Online registration is now open. To register at no cost, click here.
Book Now
Next Generation Migraine Therapies – Chicago
Conference Hotel
Hyatt Regency O’Hare Chicago
9300 Bryn Mawr Ave.
Rosemont, IL 60018
1-847-696-1234
As the largest hotel outside the city, Hyatt Regency O’Hare Chicago is home to spaces ranging from traditional ballrooms to inspiring networking areas, and top-floor reception venues. Located five minutes from O’Hare International Airport, and offering a complimentary airport shuttle, we are a comfortable and convenient location for travelers.
AHS has booked a block of hotel rooms for attendees who want to spend the night. The group rate is $169/night (+tax). The group rate expires on August 26 or when the block sells out (whichever comes first). Please book early to secure your room at the group rate. Book using this link.
PARKING
If you drive to the workshop, we have a discounted parking rate at the Hyatt Regency of $16/day (with in and out privileges).
Next Generation Migraine Therapies – Chicago
Unable to attend Next Generation Migraine Therapies in-person? Register for the Education On Demand program to view past NGMT content for up to 2.75 AMA PRA Category 1 Credits™
| Pre-recorded Lectures Available On Demand |
| Introduction and Program Overview Kathleen B. Digre, MD, FAHS |
| Migraine Diagnosis, Epidemiology, and Pathophysiology Kathleen B. Digre, MD, FAHS |
| What’s New in Acute Migraine Treatment Stewart J. Tepper, MD, FAHS |
| Behavioral Approaches in Migraine Management Dawn C. Buse, PhD, FAHS |
| What’s New in Migraine Prevention Michael Marmura, MD, FAHS |
Next Generation Migraine Therapies – Chicago
AHS gratefully acknowledges sponsorship of the 2022 Next Generation Migraine Therapies Program from our industry supporters:
BRONZE
 |
AHS gratefully acknowledges educational grant support of the 2022 Next Generation Migraine Therapies Program from our industry supporters:
| AbbVie Inc. |
| Lilly USA, LLC |
Book Now